By Sam van de Schootbrugge 11-11-2020

Which US Sectors Are Most Excited About A Vaccine?

(4 min read)
Resize text:


This week, Pfizer provided the first interim analysis of their Phase 3 vaccine study. It found their vaccine candidate to be more than 90% effective in preventing COVID-19 in participants without evidence of prior infection. This promising news means the vaccine will likely be the fastest-developed ever.

And speed matters. From a public health standpoint, over 50mn cases and 1.25mn deaths have been officially recorded. The virus will be the second-largest cause of death this year (behind heart disease) and is 20th on the list of the world’s deadliest pandemics (Chart 1).







Containment measures crucial in halting the virus’ spread have created large short-term economic costs. During Q2 2020, the World Bank estimates that average global GDP (SA) fell 7.8% QoQ, with developed economies recording a 10% drop-off. A seminal IMF working paper also found a 15% decline in industrial production within 30 days of national lockdowns.

With several developed countries returning to national lockdowns and new daily global cases and deaths reaching record levels, economies are again set for a squeeze. Although the economic impact of second and third waves will likely be less than those of wave one, certain sectors will nevertheless continue to struggle.

TO READ THIS DEEP DIVE
SUBSCRIBE TO MACRO HIVE PRIME

£39/month thereafter

For access to our Slack Chat Room, where we discuss all things markets with our researchers and subscribers

START YOUR FREE TRIAL


MOST READ

ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Stepped up PEPP purchases since the 11 March ECB meeting leave little need for any policy changes at this week’s governing council meeting...

Russia Sanctions: The Shock That Never Came (5 min read)

By Tatiana Orlova | Apr 16, 2021
The most important measure bars US entities from newly issued local sovereign debt, effective from 14 June. The ban includes debt issued by the CBR...

Weekly Vaccination Update: J&J Pause and EU Supply Schedule (1 min read)

By Sam van de Schootbrugge | Apr 14, 2021
In this prime tracker, we review the latest vaccine developments globally. This week, we’ve added some brief commentary...

PREMIUM CONTENT

ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Summary Thursday’s ECB meeting is unlikely to…

Five Things You Did Not Know About China (2 min read)

By Bilal Hafeez | Apr 13, 2021
China is a global economic superpower, yet…

Want To Join Our Community Of Leading Investors And Researchers In Our Slack Chat Room?